Therapeutic Guidelines for Atopic Dermatitis 2002

Allergology International

Volumn 54, Issue 1, 2005, Pages 45-49

  Furue, Masutaka ^a,d   Kohno, Yoichi ^b   Yamamoto, Shoso ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Anti histamine; Atopic dermatitis; Steroid; Tacrolimus; Therapeutic guidelines

Indexed keywords

ALCLOMETASONE DIPROPIONATE; AMCINONIDE; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUDESONIDE; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; DEXAMETHASONE; DEXAMETHASONE 17 VALERATE; DIFLORASONE DIACETATE; DIFLUCORTOLONE VALERATE; DIFLUPREDNATE; FLUMETASONE PIVALATE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; HALCINONIDE; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; MOMETASONE FUROATE; PREDNISOLONE; PREDNIVAL ACETATE; STEROID; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

ATOPIC DERMATITIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; MEDICAL CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SKIN CARE;

EID: 17044407161     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.45     Document Type: Review

References (3)

1. Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis. Jap. J. Dermatol. 1966;106:64-65.
2. Furue M, Terao H, Rikihisa W et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br. J. Dermatol. 2003;148:128-133.
3. The Japanese FK506 Ointment Study Group. Clinical guidance for treatment of patients with atopic dermatitis by tacrolimus ointment 0.1% and 0.03%. Rinsho Hifuka 2003;57:1217-1234 (in Japanese).